XML 29 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues [1] $ 388,645,000 $ 419,482,000 $ 403,549,000
Cost of revenues [1],[2],[3] 199,622,000 200,220,000 193,605,000
Selling and marketing [1],[2],[3] 89,145,000 108,395,000 130,509,000
Research and development [1],[2],[3] 61,802,000 76,979,000 89,023,000
General and administrative [1],[2],[3] 66,419,000 84,535,000 74,651,000
Investigation and audit related [1] 4,305,000 38,338,000 83,398,000
Amortization of intangible assets 30,076,000 32,864,000 34,823,000
Impairment of goodwill 224,272,000 0 0
Impairment of intangible asset [1] 17,308,000 0 0
Settlement of litigation, net 2,900,000 5,250,000 82,533,000
Restructuring [2] 3,263,000 11,837,000 10,510,000
Total expenses from operations 699,112,000 558,418,000 699,052,000
Loss from operations (310,467,000) (138,936,000) (295,503,000)
Interest expense, net [1] (31,526,000) (16,465,000) (661,000)
Other income (expense), net 1,654,000 (1,464,000) 15,205,000
Gain (loss) from foreign currency transactions 336,000 1,303,000 (3,151,000)
Loss before income taxes (340,003,000) (155,562,000) (284,110,000)
Income tax benefit (provision) 1,007,000 (3,706,000) 2,717,000
Net loss $ (338,996,000) $ (159,268,000) $ (281,393,000)
Net loss per common share:      
Basic and Diluted (in dollars per share) $ (5.33) $ (2.76) $ (4.90)
Weighted-average number of shares used in per share calculation - Common Stock:      
Basic and Diluted (in shares) 63,590,882 57,700,603 57,485,755
Comprehensive loss:      
Net loss $ (338,996,000) $ (159,268,000) $ (281,393,000)
Other comprehensive (loss) income:      
Foreign currency cumulative translation adjustment (1,712,000) (4,397,000) 6,168,000
Other 0 0 28,000
Total comprehensive loss (340,708,000) (163,665,000) (275,197,000)
Share-based Payment Arrangement, Noncash Expense [Abstract]      
Stock-based compensation expense 16,558,000 37,619,000 17,314,000
Cost of revenues      
Share-based Payment Arrangement, Noncash Expense [Abstract]      
Stock-based compensation expense 1,852,000 6,349,000 1,766,000
Selling and marketing      
Share-based Payment Arrangement, Noncash Expense [Abstract]      
Stock-based compensation expense 3,615,000 9,452,000 5,247,000
Research and development      
Share-based Payment Arrangement, Noncash Expense [Abstract]      
Stock-based compensation expense 1,981,000 6,580,000 2,270,000
General and administrative      
Share-based Payment Arrangement, Noncash Expense [Abstract]      
Stock-based compensation expense 9,247,000 14,770,000 8,031,000
Restructuring      
Share-based Payment Arrangement, Noncash Expense [Abstract]      
Stock-based compensation expense (137,000) 468,000 0
Investor      
Related Party Transactions [Abstract]      
Revenues 17,464,000 12,662,000 13,181,000
Interest (expense) income, net (23,494,000) (16,023,000) 672,000
Investor | Cost of revenues      
Related Party Transactions [Abstract]      
Expenses 10,490,000 11,239,000 12,956,000
Investor | Selling and marketing      
Related Party Transactions [Abstract]      
Expenses 312,000 158,000 157,000
Investor | Research and development      
Related Party Transactions [Abstract]      
Expenses 26,000 186,000 119,000
Investor | General and administrative      
Related Party Transactions [Abstract]      
Expenses 776,000 650,000 777,000
Investor | Investigation and audit related      
Related Party Transactions [Abstract]      
Expenses $ 0 $ 0 $ 16,844,000
[1] (1) Transactions with related parties are included in the line items above as follows (refer to Footnote 15, Related Party Transactions, of the Notes to Consolidated Financial Statements for additional information): 2019 2018 2017Revenues $17,464 $12,662 $13,181 Cost of revenues 10,490 11,239 12,956Selling and marketing 312 158 157Research and development 26 186 119General and administrative 776 650 777Investigation and audit related — — 16,844 Interest (expense) income, net (23,494) (16,023) 672
[2] (2) Stock-based compensation expense is included in the line items above as follows: 2019 2018 2017Cost of revenues $1,852 $6,349 $1,766Selling and marketing 3,615 9,452 5,247Research and development 1,981 6,580 2,270General and administrative 9,247 14,770 8,031Restructuring (137) 468 — $16,558 $37,619 $17,314
[3] (3) Excludes amortization of intangible assets, which is presented separately in the Consolidated Statements of Operations and Comprehensive Loss.